Distribution of myocardial fibrosis in patients with nonischemic cardiomyopathy and ventricular tachycardia based on genetic variant
Heart Rhythm · 2025
DOI: 10.1016/j.hrthm.2024.06.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Rhythm, 2025. Verfasst von Nicholas Weinand und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Fibrosis, Myocardium, Catheter Ablation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Many genetic nonischemic dilated cardiomyopathies (NICMs) cause ventricular tachycardias (VTs) originating from scar substrate identified as areas of low electrogram voltage. Substrate locations vary, and the causes of scar are not well defined. OBJECTIVE: This study evaluated VT substrate locations in genetic NICM patients undergoing VT ablation to evaluate spatial relationships between specific variants and substrate locations. METHODS: In this retrospective case series analysis, 32 patients (aged 55 ± 16 years; 94% male; left ventricular ejection fraction, 34% ± 13%) with genetic NICM referred for VT ablation between October 2018 and November 2022 at a single medical center were evaluated. Scar locations were defined as areas of low unipolar or bipolar voltage. RESULTS: Of the 32 patients evaluated, mutations in TTN (n = 11), LMNA (n = 6), PKP2 (n = 5), MYBPC3 (n = 3), DSP (n = 2), TTR (n = 1), FLNC (n = 1), AGL (n = 1), DES (n = 1), and DSG2 (n = 1) were observed. Substrates associated with mutations in TTN were observed only in basal subregions, predominantly anterior (100%) and septal (50%) regions. LMNA mutations were associated with fibrosis in mid inferolateral (60%) and apical inferolateral (60%) regions. Substrate location for individuals with PKP2 mutations was solely observed in the right ventricle, predominantly basal inferolateral regions. CONCLUSION: Understanding spatial relationships between genetic variants causing NICM and VT substrate locations can help lead to generalizable regions in patients with genetically related NICM presenting in VT, which can be investigated during ablation procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
- Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
- Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Cardiovascular Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
- Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: travis.d.richardson@vumc.org.
Zitieren
APA
Weinand, N., Hu, T., Hasegawa, K., Kanagasundram, A., Tandri, H., Stevenson, W., & Richardson, T. (2025). Distribution of myocardial fibrosis in patients with nonischemic cardiomyopathy and ventricular tachycardia based on genetic variant. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2024.06.047
Vancouver
Weinand N, Hu T, Hasegawa K, Kanagasundram A, Tandri H, Stevenson W, et al. Distribution of myocardial fibrosis in patients with nonischemic cardiomyopathy and ventricular tachycardia based on genetic variant. Heart Rhythm. 2025. doi:10.1016/j.hrthm.2024.06.047
BibTeX
@article{Weinand2025,
author = {Weinand, Nicholas and Hu, Tiffany and Hasegawa, Kanae and Kanagasundram, Arvind and Tandri, Harikrishna and Stevenson, William and Richardson, Travis},
title = {Distribution of myocardial fibrosis in patients with nonischemic cardiomyopathy and ventricular tachycardia based on genetic variant},
journal = {Heart Rhythm},
year = {2025},
doi = {10.1016/j.hrthm.2024.06.047}
}
EUVIMED